MedTrace Logo

Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED

NCT01206621 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2011-05-13

No results posted yet for this study

Summary

For the patient with acute dyspnea in the ED, early differentiation between CHF and non-CHF causes is essential for proper management. The capacity to triage patients quickly and accurately has a beneficial impact upon outcome, disposition, stratification and length of stay in the ED and required length of hospital admission.

The ability to assess pulmonary status rapidly by quantitative regional vibration technology offers significant potential advantage for earlier diagnosis. The VRI technique may provide a quick and accurate method of differentiating between dyspnea due to HF and dyspnea due to pulmonary causes; thereby improving management and outcomes.

Conditions

Sponsors & Collaborators

  • Deep Breeze

    lead INDUSTRY

Principal Investigators

  • Charles V. Pollack, MD · Pennsylvania Hospital

Eligibility

Min Age
41 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206621 on ClinicalTrials.gov